Agenus Inc. (NASDAQ: AGEN) started the day on April 01, 2021, with a price increase of 5.51% at $2.87. During the day, the stock rose to $2.941 and sunk to $2.74 before settling in for the price of $2.72 at the close. Taking a more long-term approach, AGEN posted a 52-week range of $2.25-$5.95.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 28.90%. Meanwhile, its Annual Earning per share during the time was 1.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -31.40%. This publicly-traded company’s shares outstanding now amounts to $192.97 million, simultaneously with a float of $173.55 million. The organization now has a market capitalization sitting at $556.69 million. At the time of writing, stock’s 50-day Moving Average stood at $3.75, while the 200-day Moving Average is $3.81.
Let’s gauge the efficiency of the firm, which has a total of 359 employees. It has generated 125,114 per worker during the last fiscal year. Meanwhile, its income per employee was -543,170. The stock had 35.49 Receivables turnover and 0.27 Total Asset turnover. For the Profitability, stocks operating margin was -340.25 and Pretax Margin of -440.53.
Agenus Inc. (AGEN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Agenus Inc.’s current insider ownership accounts for 0.20%, in contrast to 52.50% institutional ownership. According to the most recent insider trade that took place on Jun 17, this organization’s 10% Owner sold 141,920 shares at the rate of 3.66, making the entire transaction reach 518,831 in total value, affecting insider ownership by 16,972,968. Preceding that transaction, on Jun 16, Company’s 10% Owner sold 72,080 for 3.66, making the whole transaction’s value amount to 264,007. This particular insider is now the holder of 17,114,888 in total.
Agenus Inc. (AGEN) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported -$0.2 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.22) by $0.02. This company achieved a net margin of -434.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
Agenus Inc.’s EPS decrease for this current 12-month fiscal period is -31.40% and is forecasted to reach -1.25 in the upcoming year.
Agenus Inc. (NASDAQ: AGEN) Trading Performance Indicators
Let’s observe the current performance indicators for Agenus Inc. (AGEN). The Stock has managed to achieve an average true range (ATR) of 0.23. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.31.
In the same vein, AGEN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.06, a figure that is expected to reach -0.31 in the next quarter, and analysts are predicting that it will be -1.25 at the market close of one year from today.
Technical Analysis of Agenus Inc. (AGEN)
If we take a close look at the recent performances of Agenus Inc. (NASDAQ: AGEN), its last 5-days Average volume was 3.62 million that shows progress from its year to date volume of 3.62 million. During the previous 9 days, stock’s Stochastic %D was recorded 25.42% While, its Average True Range was 0.22.
Raw Stochastic average of Agenus Inc. (AGEN) in the period of the previous 100 days is set at 8.61%, which indicates a major fall in contrast to 30.72% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 61.68% that was lower than 67.08% volatility it exhibited in the past 100-days period.